H. Lundbeck divests Italian pharma manufacturing subsidiary
Listed Danish pharmaceutical giant H. Lundbeck is divesting its Italian manufacturing subsidiary, Lundbeck Pharmaceuticals Italy, to Flamma, a privately owned Italian contract development and manufacturing organisation (CDMO). While the exact financial terms and transaction value have not been publicly disclosed, the deal marks a significant strategic realignment for both organisations. For Lundbeck, the divestment represents a deliberate effort to streamline…